Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients with suspected endometriosis can access clinicians with specialist expertise through the NHS online hospital.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
NHS Online will be a new, optional online service allowing patients to digitally connect with clinicians across England. In January 2026, we announced the initial specialities and conditions that NHS Online will focus on. Menstrual problems that may be a sign of endometriosis will be one of the first conditions available for referral to NHS Online when it launches in 2027. This pathway being developed for NHS Online incorporates a process for investigation, management, and onward referral to specialist services within a timely manner if clinically indicated.
This means that when a patient goes to see their general practitioner, they will have the option of being referred, through their legal right to choice, to NHS Online for their care. Should a consultation be required, they will see the next available specialist, who may be anywhere in the country. Following an NHS Online assessment, if a patient requires or chooses a face-to-face consultation they will be referred to a local provider.
Patient safety will not be compromised. Clinical oversight will be robust, keeping patient safety at the heart of the process.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) prioritise research into pancreatic cancer and (b) encourage innovations in earlier diagnosis.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department invests over £1.6 billion each year on research through the National Institute for Health and Care Research (NIHR), and in 2024/25, spent £141.6 million on cancer research, signalling its high priority. This includes studies that focus specifically on pancreatic cancer as well as studies that are relevant to or include pancreatic cancer. For example, between the 2020/21 to 2024/25 financial years, the NIHR committed £1.5 million to specific pancreatic cancer studies.
One instance of this is ongoing research funded by the NIHR which aims into improve the early diagnosis of pancreatic cancer by utilising artificial intelligence as well as reducing instances of missed cancer.
The NIHR’s wider investments in research infrastructure, including facilities, services, and the research workforce, supported the delivery of 160 pancreatic cancer research studies and enabled over 8,200 people to participate in potentially life-changing research during this time period. This includes support for the PemOla trial, which is the first to explore using precision immunotherapies to treat pancreatic cancer.
The Office for Life Sciences’ Cancer Healthcare Goals programme aims to maximise and direct global industrial investment for the development and acceleration of new cancer diagnostic and therapeutic technologies and devices in the United Kingdom through: providing research investments to support the development of innovations in the early stages of the development pathway and; supporting industry to accelerate cancer diagnostic and therapeutic technologies and devices in the latter stages of development into the National Health Service.
The programme launched the £10.9 million NIHR i4i Cancer Healthcare Goals: Early Cancer Diagnosis Clinical Validation and Evaluation Call. This has funded six projects which are developing breakthrough technologies that can increase the proportion of cancers which are detected earlier in the disease course and/or target health inequalities in cancer diagnosis.
This includes the miONCO-Dx multi-cancer early detection test, developed by XGenera, which can identify 12 of the most lethal and common cancers, including pancreatic cancer, at even the earliest stages from just 100 microlitres of blood. This technology is currently testing the diagnostic test accuracy on over 20,000 patient samples with promising early results.
The NIHR continues to encourage and welcome high quality funding applications into pancreatic cancer.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to clinical trials for patients with pancreatic cancer.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is committed to ensuring that all patients, including those with pancreatic cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.
The Department funds research and research infrastructure through the National Institute for Health and Care Research (NIHR), which supports National Health Service patients, the public, and NHS organisations across England to participate in high-quality research, including clinical trials into cancers.
NIHR provides an online service called 'Be Part of Research', which promotes participation in health and social care research by allowing users to search for relevant studies and register their interest.
The forthcoming National Cancer Plan will include further details on how we will improve outcomes for cancer patients across the country. It will ensure that more patients have access to the latest treatments and technology, and to clinical trials.
The Government also supports the Rare Cancers Private Members Bill. The bill will make it easier for clinical trials, on for example pancreatic cancer, to take place in England, by ensuring the patient population can be more easily contacted by researchers.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to publish the report into the cost of clinical negligence being prepared by David Lock KC.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The rising costs of clinical negligence claims against the National Health Service in England are of great concern to the Government. Costs have more than doubled in the last 10 years and are forecast to continue rising, putting further pressure on NHS finances.
As announced in the 10-Year Health Plan for England, David Lock KC is providing expert policy advice on the rising legal costs of clinical negligence and how we can improve patients’ experience of claims. The review is ongoing, following initial advice to ministers and the recent National Audit Office’s report.
The results of David Lock’s work will inform future policy making in this area. No decisions on policy have been taken at this point, and the Government will provide an update on the work done and next steps in due course.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department for Transport:
To ask the Secretary of State for Transport, if she will support the proposal made by the Netherlands government to amend the shoulder height requirements in regulation R129 at the upcoming 77th meeting of the UN Working Party on Passive Safety in Geneva in December.
Answered by Lilian Greenwood - Government Whip, Lord Commissioner of HM Treasury
The Department for Transport noted the informal document presented by the Kingdom of the Netherlands to the 77th meeting of the UNECE Working Party on Passive Safety (GRSP) in May 2025 to amend Regulation 129 on Child Restraint Systems. An associated working document was published on 23 September for the 78th meeting of GRSP in December.
The Government treats road safety seriously and is committed to reducing the numbers of those killed and injured on our roads. Where there is clear evidence of a substantial safety issue related to the design of vehicle accessories, the Department will consider positively the evolution of international regulations and will assess this proposal carefully in advance of the next meeting of GRSP.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to announce the funding support for children’s hospices for 2026-27 onwards.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Children and young people’s hospices do incredible work to support seriously ill children and their families and loved ones when they need it most, and we recognise the incredibly tough pressures they are facing.
We are providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which, until recently, was known as the Children’s Hospice Grant.
I can also now confirm the continuation of this vital funding for the three years of the next spending review period, 2026/27 to 2028/29 inclusive. This funding will see circa £26 million, adjusted for inflation, allocated to children’s and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.
This revenue funding is intended to be spent by hospices to provide high-quality care and support for the children and the families they care for, either in the hospice or in the community, including in children's homes. They can, for example, use this funding for providing respite care for children who have high health needs, by providing physiotherapy or occupational therapy, or by providing 24/7 nursing support for a child at the end of their life.
We are also supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, whether she has made a recent assessment of the potential merits of removing the customs duty on mastectomy bras.
Answered by James Murray - Chief Secretary to the Treasury
The UK’s tariff schedule, known as the UK Global Tariff (UKGT), adheres to global classification standards. Those classify mastectomy bras under a commodity code that covers a range of other textiles.
We continue to monitor the UKGT to ensure our Most Favoured Nation tariff schedule functions as effectively as possible, supports domestic priorities, and provides a stable operating environment for businesses.
Businesses are able to request the partial or full liberalisation of the import duty applied to the products under this commodity code, including mastectomy bras, either through the online feedback form or the next business suspensions window.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what progress he has made on AI collaboration with Anthropic since 14 February 2025.
Answered by Feryal Clark
The Department has continued to deepen its collaboration with Anthropic as part of its broader strategy to strengthen the UK’s sovereign AI capabilities. This partnership forms part of the Government’s commitment to ensuring the UK is an AI maker, not just a taker. Through the Sovereign AI Unit, DSIT is working with Anthropic and other frontier AI companies to shape the development of strategically important capabilities, leveraging the UK’s strengths in talent, data and investment to secure economic and technological advantage.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Ministry of Housing, Communities and Local Government:
To ask the Secretary of State for Housing, Communities and Local Government, when she plans to respond to the correspondence from the Rt hon. Member for Godalming and Ash of 3 April 2025 requesting a meeting with the Minister for Housing and Planning to discuss the Community Infrastructure Levy.
Answered by Matthew Pennycook - Minister of State (Housing, Communities and Local Government)
As set out in previous replies to the Rt Hon Member on this subject, my Department is continuing to review the issues highlighted in the correspondence shared as part of the government’s commitment to strength the existing system of developer contributions.
I would be more than happy to meet with the Rt Hon Member and my office has contacted his with a view to finding a mutually convenient date and time.
Asked by: Jeremy Hunt (Conservative - Godalming and Ash)
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, what steps he is taking to increase support for Ukraine.
Answered by Luke Pollard - Minister of State (Ministry of Defence)
This year the UK will give more military support to Ukraine than ever before, with a £4.5 billion boost.
At the 27th Ukraine Defence Contact Group meeting, we announced a rapid surge in support, valued at around £450 million. This follows the £2.26 billion loan agreement with Ukraine earmarked for military spending.
We are absolutely committed to securing a just and lasting peace in Ukraine.